For example, lung cancer progression under the treatment by first- or second-generation EGFR inhibitors requires the analysis of EGFR T790M mutation, which sometimes can be accomplished by ctDNA testing [139, 144, 167, 168]. The gene discussed is EGFR; the disease is lung carcinoma.